SGA
Sector Gamma AS Portfolio holdings
AUM
$306M
1-Year Return
4.68%
This Quarter Return
-3.59%
1 Year Return
+4.68%
3 Year Return
+19.67%
5 Year Return
+46.47%
10 Year Return
+161.43%
AUM
$501M
AUM Growth
-$63.3M
(-11%)
Cap. Flow
-$46.1M
Cap. Flow
% of AUM
-9.2%
Top 10 Holdings %
Top 10 Hldgs %
56.05%
Holding
39
New
2
Increased
14
Reduced
13
Closed
10
Top Buys
| 1 |
Merck
MRK
|
$26.8M |
| 2 |
Dentsply Sirona
XRAY
|
$14.6M |
| 3 |
Qiagen
QGEN
|
$8.79M |
| 4 |
Cardinal Health
CAH
|
$7.65M |
| 5 |
Boston Scientific
BSX
|
$7.21M |
Top Sells
| 1 |
Pfizer
PFE
|
$21M |
| 2 |
Gilead Sciences
GILD
|
$14.4M |
| 3 |
Henry Schein
HSIC
|
$12.3M |
| 4 |
Revvity
RVTY
|
$10.4M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
$9.84M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PDCO
26
DELISTED
Patterson Companies, Inc.
PDCO
| $5.14M | 1.03% |
170,547
+28,804
| +20% | +$868K |
|
|
SAGE
27
DELISTED
Sage Therapeutics
SAGE
| $4.91M | 0.98% |
110,767
+20,029
| +22% | +$887K |
|
|
MRTX
28
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $4.6M | 0.92% |
+26,000
| New | +$4.6M |
|
29
Novavax
NVAX
$1.27B
| $2.29M | 0.46% |
11,044
-2,582
| -19% | -$535K |
|
|
30
Alnylam Pharmaceuticals
ALNY
$59.5B
| – | – |
-58,017
| Closed | -$9.84M |
|
31
Aurinia Pharmaceuticals
AUPH
$1.64B
| – | – |
-234,916
| Closed | -$3.05M |
|
32
BioMarin Pharmaceuticals
BMRN
$11B
| – | – |
-68,964
| Closed | -$5.75M |
|
33
Hologic
HOLX
$14.9B
| – | – |
-117,738
| Closed | -$7.86M |
|
|
34
Henry Schein
HSIC
$8.37B
| – | – |
-165,721
| Closed | -$12.3M |
|
35
Johnson & Johnson
JNJ
$430B
| – | – |
-30,000
| Closed | -$4.94M |
|
36
LivaNova
LIVN
$3.18B
| – | – |
-14,803
| Closed | -$1.25M |
|
|
37
Revvity
RVTY
$10B
| – | – |
-67,661
| Closed | -$10.4M |
|
38
Perrigo
PRGO
$3.23B
| – | – |
-204,732
| Closed | -$9.39M |
|
39
Regeneron Pharmaceuticals
REGN
$60.4B
| – | – |
-4,876
| Closed | -$2.72M |
|